BETALACTAMASAS DE ESPECTRO EXTENDIDO PDF

Abstract. MIRANDA GARCIA, Mª C.. Extended spectrum beta-lactamase – positive Escherichia coli: resistance. Sanid. Mil. [online]. , vol, n.4, pp Tratamiento de las infecciones por microorganismos productores de betalactamasas de espectro extendido: un nuevo reto terapéutico. Prevalencia de betalactamasas de espectro extendido en Escherichia coli, Klebsiella pneumoniae y Klebsiella oxytoca del Hospital Occidente de Kennedy.

Author: Zolokinos Vudoshakar
Country: New Zealand
Language: English (Spanish)
Genre: History
Published (Last): 6 September 2008
Pages: 114
PDF File Size: 14.90 Mb
ePub File Size: 2.61 Mb
ISBN: 860-7-29224-408-9
Downloads: 54245
Price: Free* [*Free Regsitration Required]
Uploader: Mooguzuru

Resultados De los 2.

Characterization, epidemiology, and detection of this important resistance threat. However, information of resistant isolates in this context is limited in Latin America.

Braz J Infect Dis. Int J Clin Pract. Blancoa, b, c Juan J.

See other articles in PMC that cite the published article. A nivel mundial, se ha observado el aumento en la prevalencia de E.

There was a problem providing the content you requested

A case-control study was conducted between August and December of in three Colombian tertiary-care institutions. Resultados Un total de 2.

  BHORE COMMITTEE REPORT PDF

Among clinical isolates of Enterobacteriaceae Curr Opin Infect Espevtro. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.

Prevalence of plasmid-mediated quinolone resistance determinants among oxyiminocephalosporin-resistant Enterobacteriaceae in Argentina. Please review our privacy policy.

Escherichia coli portador de betalactamasas de espectro extendido: resistencia

Changing epidemiology and clinical impact. Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Espectrro America: Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M All participating patients were asked for a urine sample. Widespread dissemination of CTX-M 15 genotype extended spectrum beta-lactamase producing Enterobacteriaceae among patients presenting to community hospitals in Southeastern United States.

Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. National Center for Biotechnology InformationU. Am Betalactamassas Infect Control.

En el presente estudio, E. Results Of the recruited patients, had a positive urine culture, of which grew E. Spanish pdf Article in xml format Article references How to cite this article Automatic translation Send this article by e-mail.

  CROUZET MUR1 PDF

Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities.

Otro de los aspectos preocupantes del clon ST de E. Phylogenetic distribution extendivo extraintestinal virulence-associated traits in Escherichia coli. Mem Inst Oswaldo Cruz.

Winning back the urinary tract. Implications of extended-spectrum beta-lactamase production in nosocomial Infections. Clinical and Laboratory Standards Institute; Clinical and epidemiological information was recorded, and a statistical analysis was performed. How to cite this article.

Manuscrit de l’auteur; accessible dans PMC nov.